Health | 203095 hits | Sep 28 6:27 am | Posted by: DrCaleb
Pfizer Inc said on Monday it had dosed the first patient in a trial testing a flu vaccine based on messenger RNA, the same technology used in the COVID-19 shots made by the U.S. drugmaker and BioNTech .
Comments
You need to be a member of CKA and be logged into the site, to comment on news.